D Schmitt, O Blanck, T Gauer, MK Fix… - Strahlentherapie und …, 2020 - Springer
This review details and discusses the technological quality requirements to ensure the desired quality for stereotactic radiotherapy using photon external beam radiotherapy as …
E Van Cutsem, A Cervantes, R Adam, A Sobrero… - Annals of …, 2016 - Elsevier
Colorectal cancer (CRC) is one of the most common malignancies in Western countries. Over the last 20 years, and the last decade in particular, the clinical outcome for patients with …
L Wilke, N Andratschke, O Blanck… - Strahlentherapie …, 2019 - search.proquest.com
Abstract The International Commission on Radiation Units and Measurements (ICRU) report 91 with the title “prescribing, recording, and reporting of stereotactic treatments with small …
J Boda-Heggemann, AC Knopf… - International Journal of …, 2016 - Elsevier
Several recent developments in linear accelerator–based radiation therapy (RT) such as fast multileaf collimators, accelerated intensity modulation paradigms like volumeric modulated …
Even though there is extensive research carried out in radiation oncology, most of the clinical studies focus on the effects of radiation on the local tumor tissue and deal with …
J Rieber, J Streblow, L Uhlmann, M Flentje, M Duma… - Lung cancer, 2016 - Elsevier
Objectives The current literature on stereotactic body radiotherapy (SBRT) for oligometastatic disease is characterized by small patient cohorts with heterogeneous …
N Andratschke, H Alheid, M Allgäuer, G Becker… - BMC cancer, 2018 - Springer
Background The intent of this pooled analysis as part of the German society for radiation oncology (DEGRO) stereotactic body radiotherapy (SBRT) initiative was to analyze the …
F Weykamp, P Hoegen, S Klüter… - Frontiers in …, 2021 - frontiersin.org
Purpose/Objective Stereotactic body radiation therapy (SBRT) has emerged as a valid treatment alternative for non-resectable liver metastases or hepatocellular carcinomas …
A Mahadevan, N Dagoglu, J Mancias, K Raven… - Journal of …, 2015 - ncbi.nlm.nih.gov
Background: Unresectable intrahepatic and hilar cholangiocarcinomas carry a dismal prognosis. Systemic chemotherapy and conventional external beam radiation and …